- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06876961
Effect of Arm Cycling Exercise on Pulmonary Functions After Colectomy In Elderly
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Al Muharraq, Bahrain
- King Hamad University Hospital,
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Sixty male patients who received a surgical removal of a diagnosed colon cancer (i.e., including right, transverse, left, sigmoid, subtotal, total, and hemicolectomy) will be included.
- Patients with a histologically confirmed diagnosis of primary colon or rectal neoplasm.
- Colectomy isolated surgeries.
- Patients will be included in this study after the immediate admission to the intensive care unit.
- The age of patients will be ≥ 65 years old.
- Patients' body mass index will be < 30 Kg/m2.
- All patients will be conscious, medically stable, and able to respond to the given commands fully.
- Patients who voluntarily cooperated with this study
- Karnofsky Performance Status > 60 and able to walk ≥ 60 m. The Karnosky Performance Status is one of the most used validated scales to define the functional status of a cancer patient. A Karnofsky Performance Status ≤ 60 indicates the inability to work and severe difficulty in carrying out activities of daily living and personal care of the cancer patient Before surgeries
Exclusion Criteria:
Men who will meet one of the following criteria will be excluded:
- relapsing cancer or metastasis cancer; simultaneous diagnosis of other neoplasms.
- Cardiac disease patients.
- Chronic inflammatory autoimmune disease
- Patients with neurological conditions limit the performance of exercises.
- Patients with diagnosed psychogenic diseases.
- Patients with musculoskeletal disorders that interfere with performing exercise programs.
- Chronic obstructive pulmonary disease, Asthma, hemodynamically unstable, significant arrhythmias, and any chronic lung disease.
- Patients require invasive/noninvasive ventilatory support.
- regular use of immunosuppressive drugs.
- Patients with cognitive disorders and unstable hemodynamics.
- patients suffering from brain death; or respiratory failure; ventilator-dependent patients: patients receiving palliative care or patients on tracheostomy.
- inability to understand given information due to language or intellectual barriers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm cycling exercise
The study group, including 30 participants, will do 20 minutes of arm cycling exercise plus the traditional physical therapy program.
|
The study involves a 20-minute arm cycling exercise twice daily for five days, starting with a warming-up and ending with a cooling-down.
The workload is gradually increased to 60-70% of maximal heart rate, with patients sitting on a back support chair with 20 degrees backward inclination.
The patient undergoes 10 minutes of deep diaphragmatic breathing exercises, 10 minutes of spirometer training, 3-set ankle pump and heel slide exercises, 10-minute sitting on the bed edge, 5 minutes of walking in the intensive care unit, and 3-set active free range of motion exercises.
|
|
Active Comparator: traditional physical therapy
The control group, including 30 participants, will do the traditional physical therapy program only
|
The patient undergoes 10 minutes of deep diaphragmatic breathing exercises, 10 minutes of spirometer training, 3-set ankle pump and heel slide exercises, 10-minute sitting on the bed edge, 5 minutes of walking in the intensive care unit, and 3-set active free range of motion exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of change of functional capacity
Time Frame: At baseline and at the day 5 post-operative
|
A 6-minute stepper test is proposed to evaluate exercise tolerance using a standardized protocol.
The test measures the number of steps performed on a stepper in 6 minutes, equivalent to the 6-minute walk test.
Patients are accustomed to the stepper for 2 minutes, followed by a 3-minute rest and 6-minute stepping period.
Heart rate and oxygen saturation are monitored, and an investigator stays behind the patient throughout the test.
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of diaphragmatic excursion using ultrasonography
Time Frame: At baseline and at the day 5 post-operative
|
Participants undergo ultrasonography to measure diaphragmatic excursion In centimeters (cm) .
The measurement will be performed using a 1- to 5-MHz ultrasound transducer in M-mode.
|
At baseline and at the day 5 post-operative
|
|
Assessing the change of forced vital capacity using spirometry
Time Frame: At baseline Day 1 and at the day 5 post-operative
|
It will be conducted noninvasively using a spirometer, measuring: forced vital capacity (FVC) in Litres is known as total exhaled volume.
|
At baseline Day 1 and at the day 5 post-operative
|
|
Assessing the change of forced expiratory volume in 1 second using spirometry
Time Frame: At baseline day 1 and at the day 5 post-operative
|
It will be conducted noninvasively using a spirometer, measuring: forced expiratory volume in 1 second (FEV1) in liters is known as volume exhaled in the first second. |
At baseline day 1 and at the day 5 post-operative
|
|
Assessing The ratio of FEV1 and FVC (FEV1/FVC)
Time Frame: at Baseline Day 1 and at the day 5 Postoperative
|
It is a Pulmonary Function measurement that evaluates the Pulmonary Functions
|
at Baseline Day 1 and at the day 5 Postoperative
|
|
Assessment of change of diaphragmatic Function using ultrasonography
Time Frame: At baseline and at the day 5 post-operative
|
Participants undergo ultrasonography to measure the Time-to-peak inspiratory amplitude (TPIAdia) of the diaphragm during tidal breathing in seconds (sec) of each hemidaphragm ( right and left ).
The measurement will be performed using a 1- to 5-MHz ultrasound transducer in M-mode.
|
At baseline and at the day 5 post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of change of potential of partial pressure of oxygen
Time Frame: At baseline and at the day 5 post-operative
|
Arterial geometry will be used to examine the effect of cycling exercise on gas exchange, including the potential of partial pressure of oxygen (PaO₂) in millimeters of mercury (mmHg)
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of bicarbonate (HCO₃)
Time Frame: At baseline and at the day 5 post-operative
|
Arterial geometry will be used to examine the effect of cycling exercise on gas exchange, including the bicarbonate (HCO₃) in millimoles per liter (mmol/L)
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of physical function in intensive care unit tested scored (PFIT)
Time Frame: At baseline and at the day 5 post-operative
|
Physical function in intensive care test score (PFIT)-s will be used to assess physical function, consisting of four components: 1-assistance, 2-marching, 3-shoulder flexion strength, and 4-knee extension strength. The strength was based on the Oxford grading system, with each component mentioned above scoring 0-3 and summed to a maximum ordinal score of 12 points, Ranging from 0-12 with a higher score reflecting a better physical function. |
At baseline and at the day 5 post-operative
|
|
Assessment of change of partial pressure of carbon dioxide (PaCO₂)
Time Frame: At baseline and at the day 5 post-operative
|
Arterial geometry will be used to examine the effect of cycling exercise on gas exchange, including the partial pressure of carbon dioxide (PaCO₂) in millimeters of mercury (mmHg).
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of potential of hydrogen (PH)
Time Frame: At baseline and at the day 5 post-operative
|
Arterial geometry will be used to examine the effect of cycling exercise on gas exchange, including the potential of hydrogen (PH)
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of lactate
Time Frame: At baseline and at the day 5 post-operative
|
Arterial geometry will be used to examine the effect of cycling exercise on gas exchange, including the lactate millimoles per liter (mmol/L).
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of anxiety (HAD scale )
Time Frame: At baseline and at the day 5 post-operative
|
The Hospital Anxiety and Depression Scale will be used.
it is a 14-item self-report screening scale with 7 items each for anxiety.
A score of 0-7 is considered normal; 8-10 indicates mild illness, 11-15 moderate illness, and scores 16-21 are suggestive of severe illness
|
At baseline and at the day 5 post-operative
|
|
Assessment of change of depression ( HAD scale )
Time Frame: At baseline and at the day 5 post-operative
|
The Hospital Anxiety and Depression Scale will be used.
it is a 14-item self-report screening scale with 7 items each for depression.
A score of 0-7 is considered normal; 8-10 indicates mild illness, 11-15 moderate illness, and scores 16-21 are suggestive of severe illness
|
At baseline and at the day 5 post-operative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Israa Youssef, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Israa-005640
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.